Adagio Medical Holdings (ADGM) Return on Sales (2023 - 2025)

Adagio Medical Holdings (ADGM) has 3 years of Return on Sales data on file, last reported at 1.84% in Q4 2025.

• Return on Sales for Q4 2025 came in at 1.84%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 1.84% (changed N/A YoY), and the FY2024 annual result was 2.35%, down 136.0% from the prior year.
• Return on Sales declined to 1.84% in Q4 2025 per ADGM's latest filing, from 0.51% in the prior quarter.
• Over five years, Return on Sales peaked at 0.29% in Q2 2024 and troughed at 3.68% in Q1 2024.
• A 3-year average of 1.28% and a median of 0.63% in 2025 frame the typical range for Return on Sales.
• On a YoY basis, Return on Sales climbed as much as 319 bps in 2025 and fell as far as 15 bps in 2025.
• A 3-year view of Return on Sales shows it stood at 0.76% in 2023, then soared by 53 bps to 0.36% in 2024, then slumped by 416 bps to 1.84% in 2025.
• Business Quant data shows ADGM's Return on Sales at 1.84% in Q4 2025, 0.51% in Q3 2025, and 0.49% in Q1 2025.